Prevalence of Myocarditis in Patients Suspected Myocardial Infarction With Non-Obstructive Coronary Arteries
1 other identifier
observational
148
0 countries
N/A
Brief Summary
This study aims to determine the prevalence of myocarditis among patients suspected of having myocardial infarction with non-obstructive coronary arteries (MINOCA) and to analyze its clinical characteristics, diagnostic markers .
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started May 2025
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 4, 2025
CompletedStudy Start
First participant enrolled
May 5, 2025
CompletedFirst Posted
Study publicly available on registry
May 12, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
April 1, 2027
May 12, 2025
May 1, 2025
1.8 years
May 4, 2025
May 4, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Prevalence of myocarditis in patients presenting with MINOCA, as diagnosed by CMR.
Studying The incidence of myocarditis in MINOCA patients
1 years
Study Arms (1)
MINOCA
Acute Myocardial infarction patient with non obstructive coronary arteries
Interventions
distinguish between true MI with significant lesion and MINOCA with insignificant lesions (less than 50%)
Eligibility Criteria
Study Population Description Myocardial infarction patients who were underwent PPCI and the coronary angiography showing insignificant lesions (stenosis less than 50% )
You may qualify if:
- All patients; diagnosed with myocardial infarction with nonobstructive coronary arteries (MINOCA)
- clinical symptoms
- ECG : ischemic changes with or without ST segment elevation
- Echocardiograpy : segmental wall motion abnormalities (SWMA)
- positive cardiac enzymes
- Coronary angiography: insignificant lesions ,the absence of culprit obstructive coronary artery disease (epicardial coronary artery stenosis ≥50%)
You may not qualify if:
- Significant coronary artery disease (\>50% stenosis) on angiography.
- Prior history of myocarditis or cardiomyopathy.
- Contraindications to CMR (e.g., pacemakers, severe renal dysfunction).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ayman khairy Mohamed Hassan
Cardiology department
- PRINCIPAL INVESTIGATOR
Khaled Mohamed Abdullah Mohamed
Cardiology department
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Resident , department of Cardiology،Principal Investigator
Study Record Dates
First Submitted
May 4, 2025
First Posted
May 12, 2025
Study Start
May 5, 2025
Primary Completion (Estimated)
March 1, 2027
Study Completion (Estimated)
April 1, 2027
Last Updated
May 12, 2025
Record last verified: 2025-05